New amendment allows BC optometrists treat glaucoma

Article

The British Columbia Association of Optometrists (BCAO) has added to the Amendments to the Optometrists Regulation to allow optometrists to treat glaucoma.

In a move that will make the treatment of glaucoma easier and more efficient in British Columbia, BC Doctors of Optometry will now be able to prescribe medications for the treatment of glaucoma. The addition to the Amendments to the Optometrists Regulation started to take effect on August 2, 2012. Prior to this move, it wasn't uncommon for a patient to need to travel over one thousand kilometers to receive treatment for glaucoma.

Dr. Surginder Sahora, the president of the British Columbia Association of Optometrists (BCAO), commented on the change,

"By allowing Doctors of Optometry to prescribe anti-glaucoma medications, patients will have greater access to timely and appropriate eye care in all areas of the province. Doctors of Optometry are educated and certified to diagnose and to prescribe treatment for glaucoma. The recent changes allow them to practice what they are already certified to do."

For more information on the BC authorization to treat glaucoma, read the full press release.


Related Articles

British Columbia's optometrists are angling for glaucoma priviledges (May 1, 2012)

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Arkansas Optometric Association legislative cochairs Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD, discuss their involvement in their bill and provide context for its relevance.
Elise Kramer, OD, FAAO, FSLS, describes her take on a multidisciplinary approach to dry eye
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Paul Karpecki, OD, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
© 2025 MJH Life Sciences

All rights reserved.